* To study the association between non-variceal UGIB and the use of NSAIDs, VKAs, DOACs and antiplatelet therapy. * To compare the severity of bleeding related to specified drugs. * To determine risk factors associated with non-variceal UGIB.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Association between non-variceal UGIB and the use of different drugs
Timeframe: through study completion, an average of 1 year
Nada Abdelfattah Ahmed Abdelatty, Resident doctor